Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania. more
Time Frame | CTCX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 23.78% | -0.33% | -1.49% |
1-Month Return | 13.02% | -4.57% | -0.37% |
3-Month Return | -11.88% | -9.96% | 3.89% |
6-Month Return | -79.81% | -5.67% | 9.34% |
1-Year Return | -92.61% | 2.53% | 25.19% |
3-Year Return | -97.06% | -1.43% | 24.7% |
5-Year Return | -97.08% | 34.73% | 85.39% |
Dec '21 | Dec '22 | Dec '23 | ||||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | ||
Cost of Revenue | - | 242.56K | 124.79K | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":51.45,"profit":true}] | ||
Gross Profit | - | (242.56K) | (124.79K) | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-24255600,"profit":false},{"date":"2023-12-31","value":-12478800,"profit":false}] | ||
Gross Margin | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | ||
Operating Expenses | 1.94M | 5.51M | 5.09M | [{"date":"2021-12-31","value":35.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.46,"profit":true}] | ||
Operating Income | (1.94M) | (5.51M) | (5.22M) | [{"date":"2021-12-31","value":-194033200,"profit":false},{"date":"2022-12-31","value":-550764100,"profit":false},{"date":"2023-12-31","value":-521728000,"profit":false}] | ||
Total Non-Operating Income/Expense | (7.04M) | (7.29M) | (11.88M) | [{"date":"2021-12-31","value":-703767500,"profit":false},{"date":"2022-12-31","value":-729290300,"profit":false},{"date":"2023-12-31","value":-1187729000,"profit":false}] | ||
Pre-Tax Income | (6.48M) | (9.05M) | (16.21M) | [{"date":"2021-12-31","value":-647892300,"profit":false},{"date":"2022-12-31","value":-905133400,"profit":false},{"date":"2023-12-31","value":-1620525200,"profit":false}] | ||
Income Taxes | 2.54M | 391.20K | (760.16K) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.42,"profit":true},{"date":"2023-12-31","value":-29.97,"profit":false}] | ||
Income After Taxes | (9.02M) | (9.44M) | (15.45M) | [{"date":"2021-12-31","value":-901538500,"profit":false},{"date":"2022-12-31","value":-944253200,"profit":false},{"date":"2023-12-31","value":-1544508900,"profit":false}] | ||
Income From Continuous Operations | (6.48M) | (9.05M) | (16.21M) | [{"date":"2021-12-31","value":-647892300,"profit":false},{"date":"2022-12-31","value":-905133400,"profit":false},{"date":"2023-12-31","value":-1620525200,"profit":false}] | ||
Income From Discontinued Operations | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | ||
Net Income | (6.48M) | (9.05M) | (15.45M) | [{"date":"2021-12-31","value":-647892300,"profit":false},{"date":"2022-12-31","value":-905133400,"profit":false},{"date":"2023-12-31","value":-1544508700,"profit":false}] | ||
EPS (Diluted) | (0.02) | 0.02 | - | [{"date":"2021-12-31","value":-109.5,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] | ||
These ratios help you determine the liquidity of the company. Higher is better.
CTCX | |
---|---|
Cash Ratio | 0.18 |
Current Ratio | 0.31 |
Quick Ratio | 0.29 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CTCX | |
---|---|
ROA (LTM) | -84.64% |
ROE (LTM) | -176.39% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CTCX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 2.66 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -1.66 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CTCX | |
---|---|
Trailing PE | 0.47 |
Forward PE | NM |
P/S (TTM) | 382.81 |
P/B | 1.91 |
Price/FCF | 2 |
EV/R | 132.79 |
EV/Ebitda | NM |
Carmell Therapeutics Corporation (CTCX) share price today is $0.2847
Yes, Indians can buy shares of Carmell Therapeutics Corporation (CTCX) on Vested. To buy Carmell Therapeutics Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CTCX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Carmell Therapeutics Corporation (CTCX) via the Vested app. You can start investing in Carmell Therapeutics Corporation (CTCX) with a minimum investment of $1.
You can invest in shares of Carmell Therapeutics Corporation (CTCX) via Vested in three simple steps:
The 52-week high price of Carmell Therapeutics Corporation (CTCX) is $4. The 52-week low price of Carmell Therapeutics Corporation (CTCX) is $0.2.
The price-to-earnings (P/E) ratio of Carmell Therapeutics Corporation (CTCX) is 0.47
The price-to-book (P/B) ratio of Carmell Therapeutics Corporation (CTCX) is 1.91
The dividend yield of Carmell Therapeutics Corporation (CTCX) is 0.00%
The market capitalization of Carmell Therapeutics Corporation (CTCX) is $4.72M
The stock symbol (or ticker) of Carmell Therapeutics Corporation is CTCX